首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1461289

全球医药中间体市场，按中间体类型、按应用、按最终用户、按地理位置

Global Pharmaceutical Intermediates Market, By Intermediate Type, By Application, By End User, By Geography

出版日期: 2024年03月11日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2024年医药中间体市场价值为436.7亿美元，预计到2031年将达到751.2亿美元，2024年至2031年年复合成长率(CAGR)为8.1%。

报告范围		报告详情
基准年：	2023年	2023/2024 年市场规模：	436.7 亿美元
历史数据：	2019年至2023年	预测期：	2024年至2031年
预测期间 2023/2024 至 2030/2031 年复合成长率：	8.10%	2030/2031 价值预测：	751.2 亿美元

全球医药中间体市占率 (%)，按地区，2024 年

过去几年，医药中间体市场取得了显着成长。医药中间体是在药物合成的各个步骤中产生的化合物。它们有助于以最少的资源有效地大量生产药物。慢性病盛行率的上升以及製药公司研发投资的增加刺激了对中间体的需求。此外，全球易患慢性病的老年人口不断增长，对市场成长产生了积极影响。然而，新中间体审批的严格监管框架以及建立生产设施的高资本要求是限制市场成长的一些挑战。总体而言，中间体在简化药物生产过程中的广泛使用预示着未来几年市场扩张的巨大机会。

市场动态：

全球医药中间体市场主要是由生活方式引起的慢性疾病（如糖尿病、癌症、心血管疾病等）发病率不断上升所推动的。另一方面，与开发新型中间体相关的高研发成本以及监管机构审批时间长等因素正在减缓市场进展。此外，老牌企业之间的激烈竞争也为新进者带来了重大挑战。然而，发展中国家日益增长的医药外包趋势为市场参与者提供了利润丰厚的机会。开发安全、环保中间体的持续技术创新将进一步支持预测期内的市场扩张。

研究的主要特点：

该报告对全球医药中间体市场进行了深入分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
它阐明了不同细分市场的潜在收入成长机会，并解释了该市场有吸引力的投资主张矩阵。
这项研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采取的竞争策略的重要见解。
它根据以下参数（例如公司亮点、产品组合、主要亮点、财务表现和策略）对全球医药中间体市场的主要参与者进行了介绍。
本研究涵盖的主要公司包括赢创、Borregaard AS、Sudarshan Pharma、AR Life Science、Actylis、Saurav Chemicals Ltd.、Lianhetech、Midas Pharma GmbH、Sanofi、BASF SE、Chiracon GmbH、Lonza、Chemcon Specialty Chemicals Limited ., Modepro SE印度列兵。有限公司、Lifechem Pharma、Sarex 和朗盛。
该报告的见解将使行销人员和公司管理当局能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球医药中间体市场报告迎合了该行业的各个利益相关者，包括投资者、供应商、产品製造商、分销商、新进业者和财务分析师。
利害关係人可以透过用于分析全球医药中间体市场的各种策略矩阵轻鬆做出决策。

介绍
北美洲
我们
加拿大
欧洲
英国
德国
义大利
法国
西班牙
俄罗斯
欧洲其他地区
亚太地区
中国
印度
日本
澳洲
韩国
东协
亚太其他地区
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地区
中东
海湾合作委员会
以色列
中东其他地区
非洲
南非
北非
中非

第 8 章：公司概况 - 全球医药中间体市场

Evonik
- 公司简介
- 产品/服务组合
- 财务绩效
- 最新动态/更新
- 战略概览
Borregaard AS
Sudarshan Pharma
AR Life Science
Actylis
Saurav Chemicals Ltd.
Lianhetech
Midas Pharma GmbH
Sanofi
BASF SE
Chiracon GmbH
Lonza
Chemcon Speciality Chemicals Limited.
Modepro India Pvt. Ltd.
Lifechem Pharma
Sarex
LANXESS

第 9 章：参考文献与研究方法

参考
研究方法论

简介目录

Product Code: CMI6740

The pharmaceutical intermediates market is estimated to be valued at USD 43.67 Bn in 2024 and is expected to reach USD 75.12 Bn by 2031, growing at a compound annual growth rate (CAGR) of 8.1% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 43.67 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	8.10%	2030/2031 Value Projection:	US$ 75.12 Bn

Global Pharmaceutical Intermediates Market Share (%), By Region, 2024

Global Pharmaceutical Intermediates Market - IMG1

The pharmaceutical intermediates market has been witnessing significant growth over the past few years. Pharmaceutical intermediates are chemical compounds produced during the various steps of pharmaceutical drug synthesis. They help in efficiently manufacturing drugs in large quantities with minimum resources. Rising prevalence of chronic diseases along with increasing R&D investments by pharmaceutical companies are fueling the demand for intermediates. Additionally, the growing geriatric population worldwide prone to chronic medical conditions is positively influencing the market growth. However, strict regulatory frameworks for the approval of new intermediates and high capital requirement for setting up manufacturing facilities are some challenges restraining the market growth. Overall, the widespread use of intermediates in streamlining drug production processes indicates huge opportunities for market expansion in the coming years.

Market Dynamics:

The global pharmaceutical intermediates market is primarily driven by the growing incidence of lifestyle-induced chronic diseases like diabetes, cancer, cardiovascular disorders, etc. Favorable government policies supporting local drug manufacturing is another key factor pushing the market growth. On the other hand, factors like high R&D costs associated with developing novel intermediates and lengthy approval times from regulatory bodies are slowing the market progress. Also, intense competition among established players poses major challenge to new entrants. However, rising pharmaceutical outsourcing trends from developing countries present lucrative opportunities for market players. Continued technological innovations to develop safe and eco-friendly intermediates will further support the market expansion over the forecast period.

Key Features of the Study:

This report provides an in-depth analysis of the global pharmaceutical intermediates market, and provides market size (USD Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global pharmaceutical intermediates market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
The key companies covered as a part of this study include Evonik, Borregaard AS, Sudarshan Pharma, A.R. Life Science, Actylis, Saurav Chemicals Ltd., Lianhetech, Midas Pharma GmbH, Sanofi , BASF SE, Chiracon GmbH, Lonza, Chemcon Speciality Chemicals Limited., Modepro India Pvt. Ltd., Lifechem Pharma, Sarex, and LANXESS.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global pharmaceutical intermediates market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmaceutical intermediates market.

Detailed Segmentation:

Intermediate Type:
- Bulk Intermediate
- Chemical Intermediate
Application:
- Anti-Infective Drugs
- Analgesics
- Antidiabetic Drugs
- Cardiovascular Drugs
- Antimicrobial Drugs
- Anti-inflammatory Drugs
- Others
End User:
- Biopharmaceutical Companies
- CMO
- CRO
- Others
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Evonik
- Borregaard AS
- Sudarshan Pharma
- R. Life Science
- Actylis
- Saurav Chemicals Ltd.
- Lianhetech
- Midas Pharma GmbH
- Sanofi
- BASF SE
- Chiracon GmbH
- Lonza
- Chemcon Speciality Chemicals Limited.
- Modepro India Pvt. Ltd.
- Lifechem Pharma
- Sarex
- LANXESS

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Intermediate Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Market Scenario - Conservative, Likely, Opportunistic
Market Opportunity Map

3. Key Insights

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Technological Advancements
Merger, Acquisition and Collaboration Scenario
Regulatory Scenario
Pricing Analysis
COVID-19 Impact Analysis
Healthcare Spending, by Country
Manufacturing Capacities
Distributors Landscape

4. Global Pharmaceutical Intermediates Market, By Intermediate Type, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2019 - 2031
- Segment Trends
Bulk Intermediate, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Chemical Intermediate, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

5. Global Pharmaceutical Intermediates Market, By Application, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2019 - 2031
- Segment Trends
Anti-Infective Drugs, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Analgesics, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Antidiabetic Drugs, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Cardiovascular Drugs, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Antimicrobial Drugs, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Anti-inflammatory Drugs, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

6. Global Pharmaceutical Intermediates Market, By End User, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2019 - 2031
- Segment Trends
Biopharmaceutical Companies, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
CMO, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
CRO, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

7. Global Pharmaceutical Intermediates Market, By Region, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, (US$ Billion)
- Market Y-o-Y Growth Comparison (%), 2019 - 2031, (US$ Billion)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Intermediate Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, By Intermediate Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest Of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Intermediate Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
China
India
Japan
Australia
South Korea
Asean
Rest Of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, By Intermediate Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, By Intermediate Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
GCC
Israel
Rest of the Middle East
Africa
- Introduction
- Market Size and Forecast, By Intermediate Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (US$ Billion)
South Africa
North Africa
Central Africa

8. Company Profiles - Global Pharmaceutical Intermediates Market

Evonik
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
Borregaard AS
Sudarshan Pharma
A.R. Life Science
Actylis
Saurav Chemicals Ltd.
Lianhetech
Midas Pharma GmbH
Sanofi
BASF SE
Chiracon GmbH
Lonza
Chemcon Speciality Chemicals Limited.
Modepro India Pvt. Ltd.
Lifechem Pharma
Sarex
LANXESS